GnRH Analogues for the Treatment of Endometriosis-Related Pain: A Narrative Review
Journal of Clinical Medicine · 11.07.2026 · 15 (14) · 5440
DOI: 10.3390/jcm15145440 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.07.2026. Verfasst von Costin Vlad Anastasiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Specialties, Faculty of Medicine, Transilvania University of Brasov, 500019 Brasov, Romania. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endometriosis is a chronic estrogen-dependent condition affecting women of reproductive age and commonly presents with dysmenorrhea, chronic pelvic pain, dyspareunia, and infertility. In a substantial proportion of patients, pain persists despite first-line hormonal treatment, making alternative pharmacologic strategies necessary. GnRH agonists and antagonists act primarily by suppressing ovarian estrogen production and thereby reduce an important hormonal driver of disease activity. Although both classes are effective for pain relief, they differ in onset of action, reversibility, tolerability, and suitability for prolonged use. This narrative review summarizes the current evidence on GnRH-based therapies for endometriosis-associated pain, with particular attention to biological rationale, clinical efficacy, safety, and the role of add-back therapy. Overall, both agonists and antagonists appear to provide clinically significant symptom improvement, especially in women who do not respond adequately to oral contraceptives or progestins. Their clinical use, however, is limited by hypoestrogenic adverse effects such as vasomotor symptoms and bone mineral density loss, which often require monitoring and adjunctive add-back therapy. Oral GnRH antagonists may offer practical advantages in selected patients through rapid action, the absence of a flare effect, and dose-adjustable hormonal suppression, although treatment choice must also consider long-term safety, cost, access, and individual patient characteristics. In summary, GnRH analogues remain useful second-line options, but treatment should be individualized according to symptom severity, previous treatment response, reproductive goals, tolerability, bone health, cost, and availability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Specialties, Faculty of Medicine, Transilvania University of Brasov, 500019 Brasov, Romania.
- Regina Maria Hospital, 500091 Brasov, Romania.
ORCID-Profile: Costin Vlad Anastasiu, Oana Gabriela Dimienescu, Ovidiu Dan Grigorescu, Marius Alexandru Moga
Zitieren
APA
Anastasiu, C. V., Dimienescu, O. G., Dull, A. M., Grigorescu, O. D., Canditu, I., & Moga, M. A. (2026). GnRH Analogues for the Treatment of Endometriosis-Related Pain: A Narrative Review. Journal of Clinical Medicine, 15(14), 5440. https://doi.org/10.3390/jcm15145440
Vancouver
Anastasiu CV, Dimienescu OG, Dull AM, Grigorescu OD, Canditu I, Moga MA. GnRH Analogues for the Treatment of Endometriosis-Related Pain: A Narrative Review. Journal of Clinical Medicine. 2026;15(14):5440. doi:10.3390/jcm15145440
BibTeX
@article{Anastasiu2026,
author = {Anastasiu, Costin Vlad and Dimienescu, Oana Gabriela and Dull, Ana-Maria and Grigorescu, Ovidiu Dan and Canditu, Iulia and Moga, Marius Alexandru},
title = {GnRH Analogues for the Treatment of Endometriosis-Related Pain: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {14},
pages = {5440},
doi = {10.3390/jcm15145440}
}
EUVIMED